Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

Background: The aim of the analysis is to assess the efficiency of the allocation of economic resources related to the use of letermovir cytomegalovirus (CMV) prophylaxis in adult seropositive recipients (R+) patients receiving an allogenic hematopoietic stem cell transplantation (HSCT), compared wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Infect Drug Resist
Päätekijät: Restelli, Umberto, Croce, Davide, Pacelli, Valeria, Ciceri, Fabio, Girmenia, Corrado
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512572/
https://ncbi.nlm.nih.gov/pubmed/31190905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S196282
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia